scholarly article | Q13442814 |
editorial | Q871232 |
P356 | DOI | 10.1111/SDI.12410 |
P698 | PubMed publication ID | 26190025 |
P50 | author | Csaba P. Kovesdy | Q5191546 |
P2860 | cites work | A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease | Q43442519 |
Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients | Q43750362 | ||
A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients | Q43812630 | ||
Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation | Q43812643 | ||
Randomized prospective comparison between erythropoietin and androgens in CAPD patients | Q43936760 | ||
Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients | Q43967511 | ||
Body size, dialysis dose and death risk relationships among hemodialysis patients | Q44173391 | ||
The effects of megestrol acetate on nutritional parameters in a dialysis population | Q44340974 | ||
Effects of body size and body composition on survival in hemodialysis patients | Q44560808 | ||
Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients | Q44695735 | ||
Normalization of protein intake by body weight and the associations of protein intake with nutritional status and survival | Q44722383 | ||
Intradialytic amino acids supplementation in hemodialysis patients with malnutrition: results of a multicenter cohort study | Q44827618 | ||
Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients | Q44948999 | ||
Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle | Q44974719 | ||
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study | Q45206183 | ||
Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report | Q45251007 | ||
Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients | Q46319405 | ||
Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients | Q46526182 | ||
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction | Q46546901 | ||
An anti-inflammatory and antioxidant nutritional supplement for hypoalbuminemic hemodialysis patients: a pilot/feasibility study | Q46593157 | ||
Waist circumference and visceral fat in CKD: a cross-sectional study | Q46623625 | ||
Body weight-for-height relationships predict mortality in maintenance hemodialysis patients | Q46899223 | ||
Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients | Q47267497 | ||
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population | Q47370500 | ||
Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes | Q48363129 | ||
Intradialytic parenteral nutrition in malnourished hemodialysis patients: a prospective long-term study | Q49171085 | ||
The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Spanish Cooperative Study of Nutrition in Hemodialysis. | Q50920049 | ||
Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. | Q50986467 | ||
Randomized double-blind trial of oral essential amino acids for dialysis-associated hypoalbuminemia. | Q51976856 | ||
Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. | Q53150829 | ||
Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. | Q53532398 | ||
Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. | Q54100242 | ||
Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension. | Q54771328 | ||
Longitudinal Associations Between Dietary Protein Intake and Survival in Hemodialysis Patients | Q57772120 | ||
Serum ferritin is a marker of morbidity and mortality in hemodialysis patients | Q57772288 | ||
Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy | Q26859689 | ||
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis | Q28262364 | ||
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy | Q28272415 | ||
Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats | Q28564508 | ||
Association of body mass index with outcomes in patients with CKD. | Q30371128 | ||
Epidemiology of dietary nutrient intake in ESRD. | Q30431685 | ||
Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease | Q30435250 | ||
Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile | Q30440296 | ||
Prevalence and prognostic significance of malnutrition in chronic renal insufficiency | Q31921863 | ||
Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters | Q33827370 | ||
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD. | Q33852363 | ||
Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis | Q33881773 | ||
Why is protein-energy wasting associated with mortality in chronic kidney disease? | Q33882103 | ||
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis | Q34016806 | ||
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis | Q34252401 | ||
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients | Q34362723 | ||
Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. | Q34453607 | ||
IL-1β receptor antagonist reduces inflammation in hemodialysis patients | Q34695324 | ||
Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease | Q34813421 | ||
Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. | Q35058723 | ||
Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis | Q35182504 | ||
Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation | Q35459884 | ||
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences | Q35569527 | ||
Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease | Q35953253 | ||
Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis | Q36243631 | ||
Association between oral nutritional supplementation and clinical outcomes among patients with ESRD | Q36492570 | ||
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients | Q36666977 | ||
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients | Q36947386 | ||
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism | Q38108694 | ||
Association between serum lipids and survival in hemodialysis patients and impact of race | Q38464997 | ||
Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial. | Q38467489 | ||
Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu | Q38469055 | ||
Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the Progressive Exercise for Anabolism in Kidney Disease (PEAK) study. | Q40169849 | ||
The nutrition management of the patient with acute renal failure | Q41096969 | ||
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial | Q41646726 | ||
P433 | issue | 1 | |
P921 | main subject | malnutrition | Q12167 |
P304 | page(s) | 28-34 | |
P577 | publication date | 2015-07-19 | |
P1433 | published in | Seminars in Dialysis | Q15761546 |
P1476 | title | Malnutrition in Dialysis Patients--The Need for Intervention Despite Uncertain Benefits | |
P478 | volume | 29 |
Q55646332 | Associations of dietary macronutrients and micronutrients with the traditional and nontraditional risk factors for cardiovascular disease among hemodialysis patients: A clinical cross-sectional study. |
Q62588867 | Malnutrition Risk in Kidney Recipients Treated With Mycophenolate Mofetil Is Associated With IMPDH1 rs2278294 Polymorphism |
Q39676582 | Malnutrition in Renal Failure: Pleiotropic Diagnostic Approaches, Inefficient Therapy and Bad Prognosis. |
Search more.